Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022 - Top-Institutions - MDSpire

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

  • By

  • John A. Snowden

  • Isabel Sánchez-Ortega

  • Selim Corbacioglu

  • Grzegorz W. Basak

  • Christian Chabannon

  • Rafael de la Camara

  • Harry Dolstra

  • Rafael F. Duarte

  • Bertram Glass

  • Raffaella Greco

  • Arjan C. Lankester

  • Mohamad Mohty

  • Bénédicte Neven

  • Régis Peffault de Latour

  • Paolo Pedrazzoli

  • Zinaida Peric

  • Ibrahim Yakoub-Agha

  • Anna Sureda

  • Nicolaus Kröger

  • May 19, 2022

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Hematology
    • Cellular Therapy

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Oncology
    • Immunotherapy

  • #3

    European Society for Blood and Marrow Transplantation (EBMT)
    European Society for Blood and Marrow Transplantation (EBMT)

    Barcelona, Catalonia

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Hematology
    • Transplantation Guidelines

  • #4

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Hematology
    • Cancer Immunotherapy

  • #5

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Hematopoietic Cell Transplantation
    • Hematology
    • Immunology

Original Source(s)

Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

  • by John A. Snowden, Isabel Sánchez-Ortega, Selim Corbacioglu, Grzegorz W. Basak, Christian Chabannon, Rafael de la Camara, Harry Dolstra, Rafael F. Duarte, Bertram Glass, Raffaella Greco, Arjan C. Lankester, Mohamad Mohty, Bénédicte Neven, Régis Peffault de Latour, Paolo Pedrazzoli, Zinaida Peric, Ibrahim Yakoub-Agha, Anna Sureda, Nicolaus Kröger

  • May 19, 2022

Related Content

Not all plasma cells are made equal: well-hidden layers of heterogeneity

POEMS syndrome with multiple ganglioside/paraneoplastic antibodies misdiagnosed as CIDP: a case report

Advancing CAR-T therapy in multiple myeloma: a critical appraisal of CARTITUDE-4 and the path toward earlier lines